Open AccessEffectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Author(s) -
Siu-Wah Chung,
Min Kyung Park,
Young Youn Cho,
Youngsu Park,
Cheol-Hyung Lee,
Hyung-Geun Oh,
Heejoon Jang,
Minseok Albert Kim,
Sun Woong Kim,
Joon Yeul Nam,
Yun Bin Lee,
Eun Ju Cho,
Su Jong Yu,
Hyo Cheol Kim,
Yoon Jun Kim,
Jin Wook Chung,
JungHwan Yoon,
Jeong-Hoon Lee
Publication year - 2021
Publication title -
journal of hepatocellular carcinoma
Language(s) - English
Resource type - Journals
ISSN - 2253-5969
DOI - 10.2147/jhc.s294440
Subject(s) - sorafenib , medicine , hepatocellular carcinoma , propensity score matching , hazard ratio , gastroenterology , cohort , transcatheter arterial chemoembolization , proportional hazards model , oncology , confidence interval
Still in real-world practice, advanced hepatocellular carcinoma (HCC) patients are treated with transarterial chemoembolization (TACE). This study compared the therapeutic effectiveness of initial TACE treatment and initial sorafenib treatment in advanced HCC patients.